» Articles » PMID: 2161939

Transforming Activity of E5a Protein of Human Papillomavirus Type 6 in NIH 3T3 and C127 Cells

Overview
Journal J Virol
Date 1990 Jul 1
PMID 2161939
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Human papillomavirus type 6 (HPV-6) is the etiologic agent of genital warts and recurrent respiratory papillomatosis. We are investigating the mechanism by which this virus stimulates cell proliferation during infection. In this paper, we report that the E5a gene of HPV-6c, an independent isolate of HPV-11, is capable of transforming NIH 3T3 cells. The E5a open reading frame (ORF) was expressed under the control of the mouse metallothionein promoter in the expression vector pMt.neo.1, which also contains the gene for G418 resistance. Transfected cells were selected for G418 resistance and analyzed for a transformed phenotype. The transformed NIH 3T3 cells overgrew a confluent monolayer, had an accelerated generation time, and were anchorage independent. In contrast, E5a did not induce foci in C127 cells, but C127 cells expressing E5a did form small colonies in suspension. The presence of the 12-kilodalton E5a gene product in the transformed NIH 3T3 cells was shown by immunoprecipitation and was localized predominantly to nuclei by an immunoperoxidase assay. A mutation in the E5a ORF was engineered to terminate translation. This mutant was defective for transformation, demonstrating that translation of the E5a ORF is required for biological activity. This is the first demonstration of a transforming oncogene in HPV-6, and the differential activity of E5a in these two cell lines should facilitate future investigations on the mechanism of transformation.

Citing Articles

Virus-mediated immunosuppression in head and neck cancer.

Miyauchi S, Roy S, Boutros N, Sharabi A Oncogene. 2025; .

PMID: 40074885 DOI: 10.1038/s41388-025-03295-2.


Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis.

Skelin J, Tomaic V Viruses. 2023; 15(11).

PMID: 38005929 PMC: 10674601. DOI: 10.3390/v15112253.


Human papillomavirus type 16 E6 induces cell competition.

Brimer N, Pol S PLoS Pathog. 2022; 18(3):e1010431.

PMID: 35320322 PMC: 8979454. DOI: 10.1371/journal.ppat.1010431.


The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.

Basukala O, Banks L Viruses. 2021; 13(10).

PMID: 34696321 PMC: 8541208. DOI: 10.3390/v13101892.


Human papillomavirus genomics: past, present and future.

Harari A, Chen Z, Burk R Curr Probl Dermatol. 2014; 45:1-18.

PMID: 24643174 PMC: 4430864. DOI: 10.1159/000355952.


References
1.
Peden K, Mounts P, Hayward G . Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe. Cell. 1982; 31(1):71-80. DOI: 10.1016/0092-8674(82)90406-8. View

2.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

3.
. Condyloma acuminatum - United States, 1966-1981. MMWR Morb Mortal Wkly Rep. 1983; 32(23):306-8. View

4.
Kasher M, Roman A . Characterization of human papillomavirus type 6b DNA isolated from an invasive squamous carcinoma of the vulva. Virology. 1988; 165(1):225-33. DOI: 10.1016/0042-6822(88)90676-9. View

5.
Kanda T, Watanabe S, Yoshiike K . Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology. 1988; 165(1):321-5. DOI: 10.1016/0042-6822(88)90694-0. View